Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Analysis & Winston Score
Lumexa Imaging Holdings appears to be a smaller or less widely covered medical device company, and detailed public information about its specific products and operations is limited. Based on the available data, it operates in the medical imaging device industry, which typically involves making equipment or tools that help doctors see inside the human body — such as scanners, cameras, or diagnostic hardware. Its customers are likely hospitals, clinics, and other healthcare providers. The company generates revenue primarily through hardware sales and potentially related services or software, which is common in the medical device space. With a gross margin of only 10.5% and a slightly negative operating margin, the business is not yet consistently profitable, suggesting it may still be in a growth or investment phase. It appears to be a mid-sized player with roughly $1.1 billion in market value. The main risk is improving profitability while competing against much larger, established imaging companies like GE HealthCare, Siemens, and Philips.
Winston Score: 11/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Weak (3/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (2/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: $11.58
Market Cap: $1.1B
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ Global Select

